SYNLOGIC, INC. Gain (Loss) on Termination of Lease
SYNLOGIC, INC. (SYBX) reported Gain (Loss) on Termination of Lease of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnTerminationOfLease · last filed 2026-03-12
- SYNLOGIC, INC. gain (loss) on termination of lease for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- SYNLOGIC, INC. gain (loss) on termination of lease for the quarter ending 2024-03-31 was $43.00K.
- SYNLOGIC, INC. gain (loss) on termination of lease for the quarter ending 2023-03-31 was $0.00.
- SYNLOGIC, INC. gain (loss) on termination of lease for fiscal 2025 was $0.00, a 100.00% decline from fiscal 2024.
- SYNLOGIC, INC. gain (loss) on termination of lease for fiscal 2024 was $3.27M.
- SYNLOGIC, INC. gain (loss) on termination of lease for fiscal 2023 was $0.00.
| Period end | Gain (Loss) on Termination of Lease 3 month | Gain (Loss) on Termination of Lease 6 month | Gain (Loss) on Termination of Lease 9 month | Gain (Loss) on Termination of Lease 12 month |
|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | |||
| 2025-06-30 | $0.00 10-Q · filed 2025-08-07 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | |||
| 2024-12-31 | $3.27M 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $3.27M 10-Q · filed 2025-11-13 | |||
| 2024-06-30 | $3.27M 10-Q · filed 2025-08-07 | |||
| 2024-03-31 | $43.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 | |||
| 2023-09-30 | $0.00 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | $0.00 10-Q · filed 2024-08-08 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |